Publications by authors named "I Aderca"

Claim this Profile
C
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial.
Evanthia Galanis, Katharine E Dooley, S Keith Anderson, Cheyne B Kurokawa, Xiomara W Carrero, Ileana Aderca

Nat Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy.
Cheyne Kurokawa, Ianko D Iankov, S Keith Anderson, Ileana Aderca, Alexey A Leontovich

J Natl Cancer Inst· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy.
I D Iankov, C B Kurokawa, A B D'Assoro, J N Ingle, E Domingo-Musibay, I Aderca

Cancer Gene Ther· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer.
Evanthia Galanis, Pamela J Atherton, Matthew J Maurer, Keith L Knutson, Sean C Dowdy, Ileana Aderca

Cancer Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restoration of epigenetically silenced SULF1 expression by 5-aza-2-deoxycytidine sensitizes hepatocellular carcinoma cells to chemotherapy-induced apoptosis.
Abdirashid Shire, Gwen Lomberk, Jin-Ping Lai, Hongzhi Zou, Norihiko Tsuchiya, Ileana Aderca

Med Epigenet· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis